Skip to main content

Advertisement

SpringerLink
Log in

Dutasteride and Prostate Cancer Risk

  • Clinical Trial Report
  • Published:
Current Urology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Thompson IM, Goodman PJ, Tangen CM, et al.: The influence of finasteride on the development of prostate cancer. N Engl J Med 2003, 349:215–224.

    Article  CAS  PubMed  Google Scholar 

  2. Thomas LN, Lazier CB, Gupta R, et al.: Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer. Prostate 2005, 63:231–239.

    Article  CAS  PubMed  Google Scholar 

  3. Andriole G, Bostwick D, Brawley O, et al.: Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial. J Urol 2004, 172:1314–1317.

    Article  CAS  PubMed  Google Scholar 

  4. Andriole GL, Roehrborn C, Schulman C, et al.: Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. Urology 2004, 64:537–541.

    Article  CAS  PubMed  Google Scholar 

  5. Cohen YC, Liu KS, Heyden NL, et al.: Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2007, 99:1366–1374.

    Article  CAS  PubMed  Google Scholar 

  6. Thompson IM, Chi C, Ankerst DP, et al.: Effect of finasteride on the sensitivity of PSA for detecting prostate cancer. J Natl Cancer Inst 2006, 98:1128–1133.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest related to this article were reported.

Author information

Authors and Affiliations

  1. Department of Urology, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, 64239, Israel

    Haim Matzkin

Authors
  1. Haim Matzkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haim Matzkin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matzkin, H. Dutasteride and Prostate Cancer Risk. Curr Urol Rep 11, 296–298 (2010). https://doi.org/10.1007/s11934-010-0129-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-010-0129-1

Keywords

Search

Navigation